CRIS : Summary for Curis, Inc. - Yahoo Finance

U.S. Markets close in 5 hrs 32 mins

Curis, Inc. (CRIS)


NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
2.57+0.04 (+1.58%)
As of 10:25AM EDT. Market open.
People also watch
ARQLCERSAGENCYTRARRY
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close2.53
Open2.60
Bid2.57 x 300
Ask2.58 x 700
Day's Range2.55 - 2.60
52 Week Range1.47 - 3.72
Volume67,390
Avg. Volume523,330
Market Cap368.01M
Beta2.39
PE Ratio (TTM)-5.65
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Curis, Inc. breached its 50 day moving average in a Bearish Manner : CRIS-US : April 24, 2017
    Capital Cube2 hours ago

    Curis, Inc. breached its 50 day moving average in a Bearish Manner : CRIS-US : April 24, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Curis, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average ... Read more (Read more...)

  • Curis, Inc. breached its 50 day moving average in a Bearish Manner : CRIS-US : April 6, 2017
    Capital Cube18 days ago

    Curis, Inc. breached its 50 day moving average in a Bearish Manner : CRIS-US : April 6, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Curis, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average ... Read more (Read more...)

  • GlobeNewswire19 days ago

    Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

    LEXINGTON, Mass., April 05, 2017-- Curis, Inc., a biotechnology company focused on the development and commercialization of innovative and effective drug candidates for the treatment of human cancers, ...